NUP50_HUMAN - dbPTM
NUP50_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID NUP50_HUMAN
UniProt AC Q9UKX7
Protein Name Nuclear pore complex protein Nup50
Gene Name NUP50
Organism Homo sapiens (Human).
Sequence Length 468
Subcellular Localization Nucleus, nuclear pore complex . Nucleus membrane
Peripheral membrane protein
Nucleoplasmic side . Localizes to the nucleoplasmic fibrils of the nuclear pore complex (By similarity). Dissociates from the NPC structure early during prophase of mito
Protein Description Component of the nuclear pore complex that has a direct role in nuclear protein import. [PubMed: 20016008 Actively displaces NLSs from importin-alpha, and facilitates disassembly of the importin-alpha:beta-cargo complex and importin recycling]
Protein Sequence MAKRNAEKELTDRNWDQEDEAEEVGTFSMASEEVLKNRAIKKAKRRNVGFESDTGGAFKGFKGLVVPSGGGRFSGFGSGAGGKPLEGLSNGNNITSAPPFASAKAAADPKVAFGSLAANGPTTLVDKVSNPKTNGDSQQPSSSGLASSKACVGNAYHKQLAALNCSVRDWIVKHVNTNPLCDLTPIFKDYEKYLANIEQQHGNSGRNSESESNKVAAETQSPSLFGSTKLQQESTFLFHGNKTEDTPDKKMEVASEKKTDPSSLGATSASFNFGKKVDSSVLGSLSSVPLTGFSFSPGNSSLFGKDTTQSKPVSSPFPTKPLEGQAEGDSGECKGGDEEENDEPPKVVVTEVKEEDAFYSKKCKLFYKKDNEFKEKGIGTLHLKPTANQKTQLLVRADTNLGNILLNVLIPPNMPCTRTGKNNVLIVCVPNPPIDEKNATMPVTMLIRVKTSEDADELHKILLEKKDA
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2 (in isoform 2)Acetylation-21.3722814378
8AcetylationMAKRNAEKELTDRNW
CCCCHHHHHHHCCCC
56.4623749302
8UbiquitinationMAKRNAEKELTDRNW
CCCCHHHHHHHCCCC
56.46-
31UbiquitinationVGTFSMASEEVLKNR
HCCCHHCCHHHHHHH
26.1621890473
31PhosphorylationVGTFSMASEEVLKNR
HCCCHHCCHHHHHHH
26.1626670566
34UbiquitinationFSMASEEVLKNRAIK
CHHCCHHHHHHHHHH
8.9421890473
52PhosphorylationRRNVGFESDTGGAFK
HCCCCCCCCCCCCCC
37.9130266825
54PhosphorylationNVGFESDTGGAFKGF
CCCCCCCCCCCCCCC
46.9630266825
55UbiquitinationVGFESDTGGAFKGFK
CCCCCCCCCCCCCCC
30.3521890473
55AcetylationVGFESDTGGAFKGFK
CCCCCCCCCCCCCCC
30.3519608861
55UbiquitinationVGFESDTGGAFKGFK
CCCCCCCCCCCCCCC
30.3519608861
55 (in isoform 2)Ubiquitination-30.35-
59AcetylationSDTGGAFKGFKGLVV
CCCCCCCCCCCEEEE
64.0025953088
59MethylationSDTGGAFKGFKGLVV
CCCCCCCCCCCEEEE
64.0091125
59UbiquitinationSDTGGAFKGFKGLVV
CCCCCCCCCCCEEEE
64.0021890473
62AcetylationGGAFKGFKGLVVPSG
CCCCCCCCEEEECCC
61.0625953088
62MethylationGGAFKGFKGLVVPSG
CCCCCCCCEEEECCC
61.0644497529
62UbiquitinationGGAFKGFKGLVVPSG
CCCCCCCCEEEECCC
61.0621890473
68PhosphorylationFKGLVVPSGGGRFSG
CCEEEECCCCCCCCC
38.1625159151
74PhosphorylationPSGGGRFSGFGSGAG
CCCCCCCCCCCCCCC
31.6725159151
76 (in isoform 2)Ubiquitination-7.34-
78PhosphorylationGRFSGFGSGAGGKPL
CCCCCCCCCCCCCCC
24.1725159151
82 (in isoform 2)Ubiquitination-28.07-
83AcetylationFGSGAGGKPLEGLSN
CCCCCCCCCCCCCCC
45.5719608861
83UbiquitinationFGSGAGGKPLEGLSN
CCCCCCCCCCCCCCC
45.5721906983
99UbiquitinationNNITSAPPFASAKAA
CCCCCCCCCCCCHHH
36.8321890473
99 (in isoform 2)Ubiquitination-36.83-
104UbiquitinationAPPFASAKAAADPKV
CCCCCCCHHHCCCCE
35.7421890473
110UbiquitinationAKAAADPKVAFGSLA
CHHHCCCCEEEHHHH
46.9021890473
115PhosphorylationDPKVAFGSLAANGPT
CCCEEEHHHHCCCCC
14.3719060867
122PhosphorylationSLAANGPTTLVDKVS
HHHCCCCCEEEECCC
33.8724972180
123PhosphorylationLAANGPTTLVDKVSN
HHCCCCCEEEECCCC
28.1124972180
127AcetylationGPTTLVDKVSNPKTN
CCCEEEECCCCCCCC
39.8325953088
127UbiquitinationGPTTLVDKVSNPKTN
CCCEEEECCCCCCCC
39.8321890473
132UbiquitinationVDKVSNPKTNGDSQQ
EECCCCCCCCCCCCC
59.89-
133PhosphorylationDKVSNPKTNGDSQQP
ECCCCCCCCCCCCCC
45.7720068231
137PhosphorylationNPKTNGDSQQPSSSG
CCCCCCCCCCCCCCC
31.9220068231
141PhosphorylationNGDSQQPSSSGLASS
CCCCCCCCCCCCCCC
32.5720068231
142PhosphorylationGDSQQPSSSGLASSK
CCCCCCCCCCCCCCC
34.8020068231
143PhosphorylationDSQQPSSSGLASSKA
CCCCCCCCCCCCCCH
42.0125159151
147PhosphorylationPSSSGLASSKACVGN
CCCCCCCCCCHHHHH
37.1020068231
148PhosphorylationSSSGLASSKACVGNA
CCCCCCCCCHHHHHH
20.7520068231
149AcetylationSSGLASSKACVGNAY
CCCCCCCCHHHHHHH
43.2226051181
158AcetylationCVGNAYHKQLAALNC
HHHHHHHHHHHHHCC
34.0423749302
158MalonylationCVGNAYHKQLAALNC
HHHHHHHHHHHHHCC
34.0426320211
158UbiquitinationCVGNAYHKQLAALNC
HHHHHHHHHHHHHCC
34.04-
164UbiquitinationHKQLAALNCSVRDWI
HHHHHHHCCCHHHHH
15.9921890473
164 (in isoform 2)Ubiquitination-15.99-
173AcetylationSVRDWIVKHVNTNPL
CHHHHHHHHCCCCCC
32.4723954790
173UbiquitinationSVRDWIVKHVNTNPL
CHHHHHHHHCCCCCC
32.47-
181GlutathionylationHVNTNPLCDLTPIFK
HCCCCCCCCCCHHHC
4.2022555962
184PhosphorylationTNPLCDLTPIFKDYE
CCCCCCCCHHHCCHH
10.90-
188AcetylationCDLTPIFKDYEKYLA
CCCCHHHCCHHHHHH
61.1826051181
188UbiquitinationCDLTPIFKDYEKYLA
CCCCHHHCCHHHHHH
61.18-
192AcetylationPIFKDYEKYLANIEQ
HHHCCHHHHHHHHHH
39.0625953088
192UbiquitinationPIFKDYEKYLANIEQ
HHHCCHHHHHHHHHH
39.0621890473
193PhosphorylationIFKDYEKYLANIEQQ
HHCCHHHHHHHHHHH
10.1026074081
201UbiquitinationLANIEQQHGNSGRNS
HHHHHHHHCCCCCCC
36.7821890473
204PhosphorylationIEQQHGNSGRNSESE
HHHHHCCCCCCCHHH
43.6625159151
208PhosphorylationHGNSGRNSESESNKV
HCCCCCCCHHHHHHH
40.9325159151
210PhosphorylationNSGRNSESESNKVAA
CCCCCCHHHHHHHHH
46.2628450419
212PhosphorylationGRNSESESNKVAAET
CCCCHHHHHHHHHHC
51.7528464451
214UbiquitinationNSESESNKVAAETQS
CCHHHHHHHHHHCCC
42.40-
219PhosphorylationSNKVAAETQSPSLFG
HHHHHHHCCCCHHCC
29.6230266825
221PhosphorylationKVAAETQSPSLFGST
HHHHHCCCCHHCCCC
24.7129255136
223PhosphorylationAAETQSPSLFGSTKL
HHHCCCCHHCCCCCC
41.3919664994
227PhosphorylationQSPSLFGSTKLQQES
CCCHHCCCCCCEEEE
18.2925159151
228PhosphorylationSPSLFGSTKLQQEST
CCHHCCCCCCEEEEE
35.8325159151
229AcetylationPSLFGSTKLQQESTF
CHHCCCCCCEEEEEE
46.1025953088
229UbiquitinationPSLFGSTKLQQESTF
CHHCCCCCCEEEEEE
46.1021890473
230UbiquitinationSLFGSTKLQQESTFL
HHCCCCCCEEEEEEE
6.8721890473
234PhosphorylationSTKLQQESTFLFHGN
CCCCEEEEEEEECCC
21.8130576142
235PhosphorylationTKLQQESTFLFHGNK
CCCEEEEEEEECCCC
24.4928555341
242AcetylationTFLFHGNKTEDTPDK
EEEECCCCCCCCCCC
58.8626051181
242UbiquitinationTFLFHGNKTEDTPDK
EEEECCCCCCCCCCC
58.86-
243PhosphorylationFLFHGNKTEDTPDKK
EEECCCCCCCCCCCC
42.9930576142
246PhosphorylationHGNKTEDTPDKKMEV
CCCCCCCCCCCCCCH
27.4425159151
247AcetylationGNKTEDTPDKKMEVA
CCCCCCCCCCCCCHH
64.8419608861
247 (in isoform 2)Ubiquitination-64.84-
249AcetylationKTEDTPDKKMEVASE
CCCCCCCCCCCHHHC
56.0523749302
255PhosphorylationDKKMEVASEKKTDPS
CCCCCHHHCCCCCHH
55.9421815630
258UbiquitinationMEVASEKKTDPSSLG
CCHHHCCCCCHHHCC
54.8521890473
259PhosphorylationEVASEKKTDPSSLGA
CHHHCCCCCHHHCCC
65.3025159151
262PhosphorylationSEKKTDPSSLGATSA
HCCCCCHHHCCCCEE
40.7922199227
263PhosphorylationEKKTDPSSLGATSAS
CCCCCHHHCCCCEEE
35.8925159151
267PhosphorylationDPSSLGATSASFNFG
CHHHCCCCEEEECCC
24.0320068231
268O-linked_GlycosylationPSSLGATSASFNFGK
HHHCCCCEEEECCCC
22.7530059200
268PhosphorylationPSSLGATSASFNFGK
HHHCCCCEEEECCCC
22.7525159151
270PhosphorylationSLGATSASFNFGKKV
HCCCCEEEECCCCCC
22.0825159151
2752-HydroxyisobutyrylationSASFNFGKKVDSSVL
EEEECCCCCCCHHHH
45.55-
275AcetylationSASFNFGKKVDSSVL
EEEECCCCCCCHHHH
45.5523954790
275MethylationSASFNFGKKVDSSVL
EEEECCCCCCCHHHH
45.5519608861
275UbiquitinationSASFNFGKKVDSSVL
EEEECCCCCCCHHHH
45.5519608861
279PhosphorylationNFGKKVDSSVLGSLS
CCCCCCCHHHHHCCC
25.9023090842
280PhosphorylationFGKKVDSSVLGSLSS
CCCCCCHHHHHCCCC
19.5223090842
284O-linked_GlycosylationVDSSVLGSLSSVPLT
CCHHHHHCCCCCCCC
22.4030059200
284PhosphorylationVDSSVLGSLSSVPLT
CCHHHHHCCCCCCCC
22.4023090842
286PhosphorylationSSVLGSLSSVPLTGF
HHHHHCCCCCCCCEE
30.8723090842
287PhosphorylationSVLGSLSSVPLTGFS
HHHHCCCCCCCCEEE
32.8023090842
291PhosphorylationSLSSVPLTGFSFSPG
CCCCCCCCEEEECCC
30.0628450419
294PhosphorylationSVPLTGFSFSPGNSS
CCCCCEEEECCCCCC
26.5922115753
296PhosphorylationPLTGFSFSPGNSSLF
CCCEEEECCCCCCCC
30.6025159151
300PhosphorylationFSFSPGNSSLFGKDT
EEECCCCCCCCCCCC
34.0422115753
301PhosphorylationSFSPGNSSLFGKDTT
EECCCCCCCCCCCCC
31.5528450419
305UbiquitinationGNSSLFGKDTTQSKP
CCCCCCCCCCCCCCC
44.56-
307PhosphorylationSSLFGKDTTQSKPVS
CCCCCCCCCCCCCCC
30.1630576142
308PhosphorylationSLFGKDTTQSKPVSS
CCCCCCCCCCCCCCC
40.7625394399
310PhosphorylationFGKDTTQSKPVSSPF
CCCCCCCCCCCCCCC
36.5130576142
311AcetylationGKDTTQSKPVSSPFP
CCCCCCCCCCCCCCC
39.3523954790
314PhosphorylationTTQSKPVSSPFPTKP
CCCCCCCCCCCCCCC
40.6029255136
315PhosphorylationTQSKPVSSPFPTKPL
CCCCCCCCCCCCCCC
30.6929255136
318 (in isoform 2)Ubiquitination-42.78-
319PhosphorylationPVSSPFPTKPLEGQA
CCCCCCCCCCCCCCC
45.7529255136
320AcetylationVSSPFPTKPLEGQAE
CCCCCCCCCCCCCCC
48.0926051181
320UbiquitinationVSSPFPTKPLEGQAE
CCCCCCCCCCCCCCC
48.09-
325 (in isoform 2)Ubiquitination-27.19-
330PhosphorylationEGQAEGDSGECKGGD
CCCCCCCCCCCCCCC
47.5529255136
346UbiquitinationEENDEPPKVVVTEVK
CCCCCCCCEEEEEEC
59.3821890473
353SumoylationKVVVTEVKEEDAFYS
CEEEEEECHHHHHHH
49.51-
353SumoylationKVVVTEVKEEDAFYS
CEEEEEECHHHHHHH
49.5128112733
353UbiquitinationKVVVTEVKEEDAFYS
CEEEEEECHHHHHHH
49.5121890473
364AcetylationAFYSKKCKLFYKKDN
HHHHCCCEEEEECCC
50.9726051181
376UbiquitinationKDNEFKEKGIGTLHL
CCCCHHHCCCEEEEE
57.32-
384AcetylationGIGTLHLKPTANQKT
CCEEEEECCCCCCCE
29.5825953088
399PhosphorylationQLLVRADTNLGNILL
EEEEECCCCCCCHHH
31.2120068231
432UbiquitinationLIVCVPNPPIDEKNA
EEEECCCCCCCCCCC
22.5821890473
450AcetylationVTMLIRVKTSEDADE
EEEEEEEECCCCHHH
36.1627452117
460AcetylationEDADELHKILLEKKD
CCHHHHHHHHHHHHC
47.9025953088
460UbiquitinationEDADELHKILLEKKD
CCHHHHHHHHHHHHC
47.9021890473

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
221SPhosphorylationKinaseCDK1P06493
PSP
221SPhosphorylationKinaseMAPK1P28482
GPS
221SPhosphorylationKinaseMAPK3P27361
GPS
315SPhosphorylationKinaseMAPK1P28482
GPS
315SPhosphorylationKinaseMAPK3P27361
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of NUP50_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of NUP50_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
IMB1_HUMANKPNB1physical
12176322
IMA1_HUMANKPNA2physical
12176322
NU153_HUMANNUP153physical
10891500
A4_HUMANAPPphysical
21832049
UBAP2_HUMANUBAP2physical
22939629
TOIP1_HUMANTOR1AIP1physical
22939629
ACACA_HUMANACACAphysical
22863883
E41L1_HUMANEPB41L1physical
22863883
WASC4_HUMANKIAA1033physical
22863883
KINH_HUMANKIF5Bphysical
22863883
T22D1_HUMANTSC22D1physical
22863883
TTI1_HUMANTTI1physical
22863883
IMA7_HUMANKPNA6physical
25416956
TP53B_HUMANTP53BP1physical
26186194
PHF10_HUMANPHF10physical
26186194
WDHD1_HUMANWDHD1physical
26186194
SMRC2_HUMANSMARCC2physical
26186194
BD1L1_HUMANBOD1L1physical
26186194
ARID2_HUMANARID2physical
26186194
IMA6_HUMANKPNA5physical
26186194
IMA7_HUMANKPNA6physical
26186194
IMA5_HUMANKPNA1physical
26186194
TAF4_HUMANTAF4physical
26186194
RBP2_HUMANRANBP2physical
26186194
KIFC1_HUMANKIFC1physical
26186194
PB1_HUMANPBRM1physical
26186194
SMRD3_HUMANSMARCD3physical
26186194
SMRD2_HUMANSMARCD2physical
26186194
SMRD1_HUMANSMARCD1physical
26186194
KLHL7_HUMANKLHL7physical
26186194
FBX28_HUMANFBXO28physical
26186194
BRD7_HUMANBRD7physical
26186194
IMA3_HUMANKPNA4physical
26186194
NU153_HUMANNUP153physical
26186194
BCL7B_HUMANBCL7Bphysical
26186194
MCE1_HUMANRNGTTphysical
26186194
SET1A_HUMANSETD1Aphysical
26186194
CDCA2_HUMANCDCA2physical
26186194
SPOP_HUMANSPOPphysical
26186194
CXXC1_HUMANCXXC1physical
26186194
MRGBP_HUMANMRGBPphysical
26186194
KI18B_HUMANKIF18Bphysical
26186194
CCD22_HUMANCCDC22physical
26344197
FLNB_HUMANFLNBphysical
26344197
GMFB_HUMANGMFBphysical
26344197
HPBP1_HUMANHSPBP1physical
26344197
IMDH2_HUMANIMPDH2physical
26344197
SYNC_HUMANNARSphysical
26344197
NU153_HUMANNUP153physical
26344197
PAIP1_HUMANPAIP1physical
26344197
PFD4_HUMANPFDN4physical
26344197
PLEC_HUMANPLECphysical
26344197
AAPK1_HUMANPRKAA1physical
26344197
PSME3_HUMANPSME3physical
26344197
RANG_HUMANRANBP1physical
26344197
SBDS_HUMANSBDSphysical
26344197
STXB1_HUMANSTXBP1physical
26344197
KIFC1_HUMANKIFC1physical
28514442
MCE1_HUMANRNGTTphysical
28514442
WDHD1_HUMANWDHD1physical
28514442
BD1L1_HUMANBOD1L1physical
28514442
KLHL7_HUMANKLHL7physical
28514442
SPOP_HUMANSPOPphysical
28514442
ARID2_HUMANARID2physical
28514442
PB1_HUMANPBRM1physical
28514442
CXXC1_HUMANCXXC1physical
28514442
PHF10_HUMANPHF10physical
28514442
NU153_HUMANNUP153physical
28514442
CDCA2_HUMANCDCA2physical
28514442
BCL7B_HUMANBCL7Bphysical
28514442
BRD7_HUMANBRD7physical
28514442
SET1A_HUMANSETD1Aphysical
28514442
FBX28_HUMANFBXO28physical
28514442
KI18B_HUMANKIF18Bphysical
28514442
SMRD2_HUMANSMARCD2physical
28514442
SMRC2_HUMANSMARCC2physical
28514442
SMRD3_HUMANSMARCD3physical
28514442
SMRD1_HUMANSMARCD1physical
28514442
IMA3_HUMANKPNA4physical
28514442
IMB1_HUMANKPNB1physical
28514442
IMA7_HUMANKPNA6physical
28514442
TP53B_HUMANTP53BP1physical
28514442
IMA6_HUMANKPNA5physical
28514442
IMA5_HUMANKPNA1physical
28514442
MARF1_HUMANKIAA0430physical
27173435
PAN2_HUMANPAN2physical
27173435
NISCH_HUMANNISCHphysical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of NUP50_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-83, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-221, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-221, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-221, AND MASSSPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-219 AND SER-221, ANDMASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-221, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-221, AND MASSSPECTROMETRY.

TOP